Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from IonQ's 2026 Annual Meeting of Stockholders held on June 16, 2026, covering three proposals: election of Class II directors (Kathryn K. Chou and William F. Scannell), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents final voting tallies for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
RYTHM held its 2026 Annual Meeting of Stockholders on June 16, 2026, with voting results on three proposals: election of seven directors, ratification of GuzmanGray as independent auditor, and approval of an amendment to the 2022 Omnibus Equity Incentive Plan increasing available shares by 115,000.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
Item 5.07
Shareholders approved an Extension Amendment at an extraordinary general meeting on June 18, 2026, extending the business combination deadline from June 20, 2026 to March 20, 2027, with 15,786,622 votes in favor, 1,468,989 against, and 400,036 abstentions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-18
Item 5.07
Live Oak Acquisition Corp. V shareholders voted at an extraordinary general meeting on June 16, 2026, approving all 14 proposals by substantial majorities, including the business combination with Teamshares, domestication, charter amendments, equity incentive plans, Nasdaq listing approval, director elections, and an insider letter amendment. The approval clears the path for the transaction to close.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 99%
filed 2026-06-18
Item 5.07
This Item 5.07 disclosure reports the final voting results from WisdomTree's June 17, 2026 Annual Meeting of Stockholders, certified by the independent inspector of election. The filing details results for three proposals: election of nine directors, ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with overwhelming majorities (97.39%–99.95% for director elections, 99.24% for auditor ratification, and 98.66% for compensation approval).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from Hercules Capital's 2026 Annual Meeting of Stockholders held on June 18, 2026. The filing presents detailed vote tallies for six proposals including director election, executive compensation advisory votes, equity plan amendments, and auditor ratification. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose explicitly states voting outcomes with vote counts for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Designer Brands held its Annual Meeting of Shareholders on June 17, 2026, with shareholders voting on four proposals: election of four Class I directors (Sonnenberg, Tanenbaum, Cobb, and Howe), ratification of Deloitte & Touche LLP as independent auditor, advisory approval of named executive officer compensation, and approval of six amendments to the Company's Code of Regulations. All proposals passed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This Item 5.07 discloses the results of Xencor's 2026 Annual Meeting of Stockholders held on June 16, 2026, with detailed voting tallies for four proposals: election of nine directors, ratification of KPMG LLP as independent auditor, approval of a 4,000,000-share increase to the 2023 Equity Incentive Plan, and an advisory vote on named executive officer compensation. All proposals passed with substantial majorities. This is a routine but material disclosure of shareholder meeting outcomes required by Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from Supernus Pharmaceuticals' June 18, 2026 annual meeting, including tabulated votes for four proposals: election of Class I directors, say-on-pay compensation approval, auditor ratification, and equity plan amendment. The filing directly matches Item 5.07 requirements and presents the definitive voting outcomes that are material to investors' understanding of corporate governance and shareholder sentiment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This Item 5.07 disclosure presents the results of Veeva's Annual Meeting of shareholders held on June 17, 2026, including voting outcomes for director elections (Proposal 1) and auditor ratification (Proposal 2). The filing explicitly states voting results for each director nominee and the appointment of KPMG LLP as independent auditor, which are material governance matters affecting investor assessment of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Keurig Dr Pepper held its Annual Meeting of Stockholders on June 16, 2026, with shareholders voting on four proposals: election of nine directors, advisory vote on executive compensation, ratification of Deloitte & Touche LLP as auditor, and approval of the 2026 Omnibus Stock Incentive Plan. Detailed voting results (For, Against, Abstentions, Broker Non-Votes) for each proposal are disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
Item 5.07
This Item 5.07 disclosure reports the results of a shareholder vote by written consent on June 15, 2026, in which majority stockholders (75.39% of outstanding shares) approved the election of Jeffrey S. Gilliam as a director and an advisory vote on named executive officer compensation. The filing explicitly states these matters were "approved by the Majority Consenting Stockholders" and will become effective on July 7, 2026, following the 20-day Rule 14c-2 waiting period. This is a classic shareholder vote result disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Genprex held its 2026 Annual Meeting of Stockholders on June 18, 2026, with shareholders voting on five proposals: election of directors (Moreno Toscano and Confer), ratification of WithumSmith+Brown as auditor, advisory vote on named executive officer compensation, approval of the Amended 2018 Equity Incentive Plan (increasing authorized shares by 1,850,000), and approval of a reverse stock split amendment. All proposals received shareholder approval with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
PDF Solutions held its Annual Meeting of Stockholders on June 16, 2026, with shareholders voting on five proposals: election of Class I directors (Joseph R. Bronson and Ye Jane Li), ratification of BPM LLP as auditor, approval of the Eleventh Amended and Restated 2011 Stock Incentive Plan, approval of the Third Amended and Restated 2021 Employee Stock Purchase Plan, and a non-binding advisory vote on 2025 named executive officer compensation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from BK Technologies' 2026 Annual Meeting held on June 18, 2026. The filing reports the outcomes of three proposals: election of seven directors, ratification of Cherry Bekaert LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This 8-K Item 5.07 discloses the results of Clipper Realty's 2025 Annual Meeting of Stockholders held on June 17, 2026, including voting tallies for three proposals: election of seven directors, ratification of PKF O'Connor Davies as independent auditor, and advisory approval of named executive officer compensation. All proposals were approved by stockholders, with detailed vote counts provided for each director nominee and proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from M-tron Industries' June 16, 2026 Annual Meeting. The filing reports voting outcomes for four proposals: election of seven directors, advisory vote on named executive officer compensation, approval of the 2022 Incentive Plan amendment, and ratification of the independent auditor. All four proposals were approved by requisite stockholder vote, with detailed vote tallies provided for each nominee and proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This Item 5.07 disclosure presents the complete voting results from Miami International Holdings' Annual Meeting of Stockholders held on June 16, 2026, covering four proposals: election of fifteen directors, advisory say-on-pay vote, frequency of future say-on-pay votes, and ratification of KPMG LLP as independent auditor. The tabular presentation of vote counts (For, Against, Withheld, Abstain, Broker Non-votes) for each proposal is the standard format for shareholder vote results and directly matches the shareholder_vote_results event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This Item 5.07 filing discloses the results of Embassy Bancorp's 2026 annual shareholder meeting held on June 17, 2026, including voting outcomes for the election of two Class 1 Directors (Frank "Chip" Banko, III and Geoffrey F. Boyer, each receiving approximately 93% of votes cast) and ratification of Baker Tilly US, LLP as independent auditor (99.70% approval). The disclosure directly matches the shareholder_vote_results event type and is material as it confirms board composition and auditor appointment through shareholder action.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 16, 2026. The filing reports voting outcomes for two proposals: (1) election of Class I directors Julie A. Cullivan and John C.M. Farquhar, and (2) ratification of PricewaterhouseCoopers LLP as independent auditor. Both proposals passed with substantial majorities. This is a material event as it reflects stockholder approval of board composition and auditor selection.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-18
EX-99.2
The Company's annual general and special meeting of shareholders held on June 17, 2026 approved three material matters: election of six directors, appointment of Deloitte LLP as auditors, and approval of a special resolution to consolidate and subsequently split the Company's common shares.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
The filing discloses results of Verano Holdings Corp.'s 2026 Annual Meeting of Stockholders held on June 18, 2026, under Item 5.07. Four proposals were submitted to stockholder vote: election of five directors, advisory approval of named executive officer compensation (Say-on-Pay), ratification of independent auditor Macias Gini & O'Connell LLP, and reapproval of the Stock and Incentive Plan. All proposals passed with substantial majorities, making this a routine but material shareholder vote disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
The filing discloses results of the 2026 Annual Meeting of stockholders held on June 18, 2026, including election of six directors, ratification of Grant Thornton LLP as independent auditor, and approval of the Amended and Restated Incentive Award Plan with voting tallies for each proposal. This is a classic Item 5.07 shareholder vote results disclosure, material to investors as it confirms board composition and equity plan expansion (3,000,000 additional shares authorized).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
The filing discloses Item 5.07 results from Manhattan Bridge Capital's 2026 Annual Meeting of Shareholders held on June 18, 2026, including voting results for the election of six directors (Assaf Ran, Lyron Bentovim, Eran Goldshmit, Michael Jackson, Vanessa Kao, and Phillip Michals) and advisory approval of Hoberman & Lesser, LLP as independent auditors. This is a standard shareholder vote results disclosure that is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
The filing discloses results from Calidi Biotherapeutics' 2026 Annual Meeting of Stockholders held on June 12, 2026, under Item 5.07. Four proposals were voted on and approved: election of Scott Leftwich as Class III Director, ratification of CBIZ CPAs P.C. as auditor, approval of a reverse stock split (1-for-2 to 1-for-16 ratio at board discretion), and amendment to the 2023 Equity Incentive Plan to increase authorized shares from 282,815 to 1,950,000. The reverse stock split and equity plan amendment are material corporate actions affecting share structure and equity compensation capacity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
The 8-K discloses results of the June 15, 2026 Annual Meeting of Stockholders under Item 5.07, reporting voting outcomes for three matters: election of five directors (with vote tallies for each nominee), advisory approval of named executive officer compensation, and ratification of Grassi & Co., CPAs as independent auditor. These are standard shareholder vote results that materially inform investors about governance and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
The filing discloses Item 5.07 results from NetSol Technologies' annual shareholder meeting held June 18, 2026, including voting outcomes for three proposals: election of seven directors (with detailed vote tallies for each), advisory approval of named executive officer compensation (77.51% in favor), and ratification of Fortune CPA, Inc. as auditors (98.64% in favor). This is a standard shareholder vote results disclosure material to investors assessing governance and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 17, 2026, filed under Item 5.07. The filing reports voting outcomes on four proposals: election of eight directors, ratification of BDO USA as independent auditor, Say-on-Pay advisory vote approval, and Say-on-Frequency advisory vote (annual frequency approved). The detailed vote tallies for each proposal and nominee are provided, making this a textbook shareholder_vote_results event that is material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Recursion Pharmaceuticals' 2026 annual meeting of stockholders held on June 17, 2026. The filing presents voting results for three proposals: election of Class II directors (Najat Khan and Franziska Michor), advisory approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. These are routine but material shareholder votes that affect corporate governance and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from Caribou Biosciences' June 17, 2026 annual meeting of stockholders, filed under Item 5.07. The filing presents voting tallies for four proposals: election of three Class II directors (all passed), ratification of Deloitte & Touche LLP as auditor (passed), approval of officer exculpation amendment (failed), and approval of meeting adjournment (passed). The election of directors and auditor ratification are material governance events affecting investor assessment of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from Chain Bridge Bancorp's June 17, 2026 Annual Meeting of Stockholders. The filing reports final vote tallies for two proposals: (1) election of thirteen directors, with detailed vote counts (For/Against/Abstain/Broker Non-Votes) for each nominee, and (2) ratification of Yount, Hyde & Barbour, P.C. as independent auditor. This is a textbook Item 5.07 shareholder vote results disclosure, and the election of directors and auditor ratification are material governance matters affecting investor assessment of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from Sionna Therapeutics' Annual Meeting of Stockholders held on June 17, 2026. The filing reports the voting outcomes for two proposals: (1) election of four Class II directors (H. Edward Fleming, Jr., Marcella Kuhlman Ruddy, Peter A. Thompson, and Joanne Louise Viney), and (2) ratification of Deloitte & Touche LLP as independent auditor. All nominees were elected and the auditor appointment was ratified. This is a routine but material disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Vertiv's 2026 Annual Meeting of Stockholders held on June 17, 2026. The filing presents final voting tallies for three proposals: election of eleven directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The detailed vote counts (For, Against, Abstentions, Broker Non-Votes) for each proposal are the core content of the disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
Item 5.07
Centrus Energy held its 2026 annual meeting of stockholders on June 18, 2026, with voting results disclosed for five proposals: election of six directors, say-on-pay advisory vote, amendment to certificate of incorporation regarding officer exculpation, approval of the Section 382 Rights Agreement extension, and ratification of Deloitte & Touche LLP as independent auditors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of the Annual Meeting of Stockholders held on June 17, 2026. The filing presents final voting tallies for two proposals: election of three Class II directors (Eric Grossberg, Attica A. Jaques, and Gavin M. Turner) and ratification of BDO USA, PC as independent auditor. Both proposals passed. Director elections are material governance events affecting the composition of the board.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of DocGo's 2026 Annual Meeting of Stockholders held on June 16, 2026. The filing presents voting outcomes on six matters: election of two Class II directors (Vina Leite and James M. Travers), advisory approval of named executive officer compensation, approval of a reverse stock split (1-for-5 to 1-for-10), rejection of a corporate opportunity waiver amendment, rejection of an officer exculpation amendment, and ratification of Urish Popeck & Co., LLC as independent auditor. The reverse stock split approval and director elections are material corporate governance events affecting shareholder interests.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
Item 5.07
Stockholders voted at the June 17, 2026 Annual Meeting of Stockholders on three proposals: election of directors (David M. Guernsey and James A. MacCutcheon), ratification of Grant Thornton LLP as independent auditor, and advisory approval of named executive officer compensation. Detailed voting tallies for each proposal are disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from ServiceTitan's June 17, 2026 Annual Meeting of Stockholders under Item 5.07. The filing reports final voting tallies for three proposals: election of three Class II directors (Michael Brown, Byron Deeter, and Vahe Kuzoyan), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of annual say-on-pay votes. All three proposals passed with substantial majorities, making this a routine but material governance disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This Item 5.07 filing discloses the results of Editas Medicine's 2026 Annual Meeting of Stockholders held on June 17, 2026, including voting outcomes on three matters: election of Class I directors (Bernadette Connaughton and Elliott Levy, M.D.), advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing presents vote tallies (For, Against, Withheld, Abstaining, and Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
Item 5.07
Solitario Resources held its Annual Meeting of Shareholders on June 17, 2026, with voting results disclosed on three matters: election of six directors, advisory vote on executive compensation, and ratification of auditors. The filing reports detailed vote tallies for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from Coinbase's June 16, 2026 annual meeting, reporting the election of nine directors and ratification of Deloitte & Touche LLP as independent auditor. The filing presents detailed vote tallies for each nominee and proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Lifeway Foods held its 2026 Annual Meeting of Shareholders on June 17, 2026, with voting results on four proposals: election of seven directors (Kirk Chartier, Juan Carlos Dalto, Rachel Drori, Andee Harris, Susie Hultquist, Dorri McWhorter, and Julie Smolyansky), ratification of Grant Thornton LLP as independent auditors, advisory approval of executive compensation, and election of Jason Scher. Detailed vote tallies for each proposal are disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from Adicet Bio's June 17, 2026 Annual Meeting of Stockholders. The filing reports final voting tallies for three proposals: election of Class II directors (Chodakewitz, Dubin, Grissinger), non-binding advisory vote on named executive officer compensation, and ratification of KPMG LLP as independent auditor. All three proposals passed with substantial majorities, making this a routine but material governance disclosure that affects investor understanding of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from Zentalis Pharmaceuticals' June 16, 2026 Annual Meeting of Stockholders. The filing reports the outcomes of three proposals: election of two Class III directors (David Johnson and Jan Skvarka, Ph.D.), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three items passed. This is a routine but material disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from Nautilus Biotechnology's June 17, 2026 annual meeting, covering four matters: election of Class II directors (Parag Mallick and Farzad Nazem), ratification of PricewaterhouseCoopers LLP as independent auditor, advisory vote on executive compensation, and advisory vote on frequency of future Say on Pay votes. The filing presents detailed voting tallies for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from GoodRx's Annual Meeting of Stockholders held on June 16, 2026. The filing reports final vote tallies for three proposals: election of three Class III directors (Wendy Barnes, Ronald E. Bruehlman, and Gregory Mondre), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure includes vote counts (FOR, AGAINST, WITHHELD, ABSTAINED) and broker non-votes for each proposal, with all three proposals passing. This is a quintessential Item 5.07 shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This 8-K Item 5.07 discloses the final voting results from Rackspace Technology's June 18, 2026 annual meeting of stockholders, including four proposals: election of two Class III directors (Gajen Kandiah and Michael Weston), ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2020 Equity Incentive Plan. All proposals passed with substantial majorities. This is a routine but material shareholder vote results disclosure required by Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from SoFi's June 17, 2026 annual meeting of stockholders. The filing reports voting outcomes on three proposals: election of ten directors, non-binding advisory vote on executive compensation, and ratification of Deloitte & Touche LLP as independent auditor. All three proposals passed with substantial majorities. This is a routine but material Item 5.07 disclosure required by SEC rules following stockholder meetings.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from the June 17, 2026 annual meeting of stockholders. The filing reports voting outcomes for two proposals: the election of Ali Kashani and Touraj Parang as Class III directors, and the ratification of PwC as independent auditor. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose explicitly presents vote tallies (votes for, against, abstaining, and broker non-votes) for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from OmniAb's 2026 Annual Meeting held on June 17, 2026, filed under Item 5.07. The filing reports final voting tallies for two proposals: election of two Class I directors (Jennifer Cochran and Matthew W. Foehr) and ratification of Ernst & Young LLP as independent auditor. Both proposals passed with substantial majorities. This is a material event as it reflects shareholder approval of board composition and auditor selection.
View raw filing on EDGAR →